These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39122144)

  • 1. Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin.
    Lomakin IB; Devarkar SC; Grada A; Bunick CG
    J Invest Dermatol; 2024 Nov; 144(11):2553-2561.e3. PubMed ID: 39122144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism.
    Lomakin IB; Devarkar SC; Patel S; Grada A; Bunick CG
    Nucleic Acids Res; 2023 Apr; 51(6):2915-2930. PubMed ID: 36864821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene,
    Aoki S; Nakase K; Nakaminami H; Wajima T; Hayashi N; Noguchi N
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
    J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
    BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm of Cutibacterium acnes: a target of different active substances.
    Ruffier d'Epenoux L; Fayoux E; Veziers J; Dagnelie MA; Khammari A; Dréno B; Corvec S
    Int J Dermatol; 2024 Nov; 63(11):1541-1550. PubMed ID: 38760974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
    Nakase K; Okamoto Y; Aoki S; Noguchi N
    J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial toner exhibits bactericidal effect against Cutibacterium acnes via keratin and sebum plug penetration.
    Hamada S; Nakamura Y; Gomi M
    J Microorg Control; 2024; 29(2):63-73. PubMed ID: 38880618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility of
    Zhu T; Zhu W; Wang Q; He L; Wu W; Liu J; Li Y; Sun D
    BMJ Open; 2019 Feb; 9(2):e022938. PubMed ID: 30782869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
    Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
    Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.